Sanuwave Health Profit Margin 2010-2024 | SNWVD

Current and historical gross margin, operating margin and net profit margin for Sanuwave Health (SNWVD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sanuwave Health net profit margin as of June 30, 2024 is -13.79%.
Sanuwave Health Annual Profit Margins
Sanuwave Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $0.056B $0.020B
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.081B 1.96
Ocuphire Pharma (IRD) United States $0.031B 0.00
Top KingWin (WAI) China $0.007B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.003B 0.00